← Open Payments lookup

MARK MARTINDALE: Open Payments

NPI 1508416785 · COEUR D ALENE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,383 in 73 payments from 19 companies in 2025. Trend: 2023 $490 · 2024 $1,208 · 2025 $1,383

Food & beverage: $1,383
CompanyPaymentsAmount
ABBVIE INC.18$289
AstraZeneca Pharmaceuticals LP9$180
Axsome Therapeutics, Inc.8$171
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$96
Otsuka America Pharmaceutical, Inc.4$84
Alkermes, Inc.4$78
Lilly USA, LLC4$75
Takeda Pharmaceuticals U.S.A., Inc.3$59
Corcept Therapeutics3$57
Novo Nordisk Inc3$54

Products named: UBRELVY, Auvelity, REXULTI, AIRSUPRA, VRAYLAR, CAPLYTA, LYBALVI, FARXIGA.

Industry payments across ID — which companies pay providers there.